In conclusion, this study has identified somatic NLRP3 mosaicism as the etiology of late onset but otherwise typical CAPS in 8% of patients seen in the adult UK national CAPS treatment service. The gene discussed is NLRP3; the disease is cryopyrin-associated periodic syndrome.